查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1716881

心臟POC检测设备市场（依产品类型、应用和最终用户）－2025-2030年全球预测

Cardiac POC Testing Devices Market by Product, Device Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计心臟 POC 检测设备市场规模在 2023 年将达到 13.6 亿美元，在 2024 年将达到 15.2 亿美元，预计年复合成长率为 12.36%，到 ​​2030 年将达到 30.8 亿美元。

主要市场统计数据
基准年2023年 13.6亿美元
预计2024年 15.2亿美元
预测年份 2030 30.8亿美元
复合年增长率（%） 12.36%

由于技术进步、临床需求变化以及对更快、更可靠诊断的需求等因素的共同作用，心臟照护现场(POC) 检测市场得到了快速发展。这个充满活力的领域正在重新定义医疗保健提供者筛检、诊断和管理心臟病的方式。生物标记检测和可携式设备工程的最新趋势已经产生了在床边或远端位置快速评估心臟健康的高效方法。

诊断技术的创新和精确对于及时介入心臟紧急情况至关重要。随着患者照护趋势转向分散和以患者为中心的模式，心臟 POC 测试设备的相关性和应用正在扩大。随着先进的生物标记测试和复杂的仪器工程的整合满足了提高准确性和操作灵活性的迫切需求，这些设备的前景有望继续转型和成长。

本全面概述从各个角度审视了心臟 POC 测试市场，揭示了不断变化的市场变化、详细的细分见解、区域商业机会、主要企业、可行的战略建议，以及对决策者利用这些趋势的强烈呼吁。

重新定义心臟POC检测的变革性转变

近年来，在技术突破和临床需求变化的推动下，心臟 POC 检测领域发生了变化。技术创新的激增促进了新诊断方法的开发，以增强对心臟病的早期发现和持续监测。这种转变体现在准确性、速度的提高以及向患者更近距离地提供检测解决方案的能力，最终有助于改善患者的治疗效果。

这项变化的关键驱动因素包括数位健康工具和人工智慧辅助诊断的整合，这简化了结果的解释并实现了更个人化的治疗途径。小型化和感测器技术的进步使得设备更加可携式、更易于使用，增强了它们在各种医疗保健环境中的作用。此外，专注于减少心臟生物标记检测的周转时间以及自动化系统的整合有助于减少关键时刻的诊断延迟。

这些动态变化正在创造一种市场环境，在这种环境中，快速、准确的诊断不仅​​是可取的，而且是必不可少的。随着全球医疗保健系统不断追求更高的效率和更好的患者照护，设备功能和诊断准确性的不断改进无疑将树立未来的标准并为市场成长铺平新的道路。

市场区隔分析的关键见解

了解市场区隔的复杂层次结构为识别心臟 POC 测试市场中的机会和挑战提供了坚实的框架。根据产品，市场分为心臟生物标记测试、耗材及配件、以及设备等部分。心臟生物标记测试部分进一步细分为特定测试，例如 B 型利钠肽、肌酸激酶同工酶 (CK-MB) 分数、D-二聚体测试、肌红蛋白测试和肌钙蛋白测试。同时，透过分析仪器和成像与监控设备的视角探索设备部分，强调分析性能和即时监控能力的重要性。

从设备类型来看，市场可分为桌上型 POC 设备、手持式 POC 设备和穿戴式 POC 设备，每种设备根据临床需求、便携性和易用性都有各自的优点和缺点。基于应用的细分进一步将市场划分为诊断和筛检以及监测，反映了这些设备在心臟病的早期检测和持续管理中发挥的双重作用。此外，根据最终用户（分为门诊手术中心、诊断实验室、家庭环境和医院）进行的分析，突显了这些技术在各种护理环境中的多种用途。

这种细粒度的细分策略将技术规格与实际应用相结合，以揭示关键趋势和要求。这使得相关人员不仅能够了解所提供产品的技术多样性，还能了解采用这些诊断创新的各种临床环境。这些见解为制定针对每个细分市场细微需求的针对性策略铺平了道路，确保产品开发和上市符合新兴市场需求和患者照护模式。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球心臟病盛行率和老龄人口成长
      • 致力于早期发现与诊断患者
      • 政府积极支持心臟健康
    • 限制因素
      • 心臟POC检测设备产品召回的潜在风险
    • 机会
      • 推出基于肌钙蛋白的新型专有测试
      • 积极的投资和Start-Ups生态系统
    • 任务
      • 心臟POC检测设备准确性的限制和担忧
  • 市场区隔分析
    • 产品：一系列心臟 POC 检测设备的监管核准
    • 设备类型：探索提供便利的居家照护的可穿戴 POC 设备
    • 应用：有效的诊断和筛检程序在心臟病管理中发挥关键作用
    • 最终使用者：医院提供的全面综合护理，改善心臟健康
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章心臟POC检测设备市场（依产品）

  • 心臟生物标记检测
    • B型利钠肽
    • 肌酸激酶同工酶 [CK-MB] 分数
    • D-二聚体检测
    • 肌红蛋白检测
    • 肌钙蛋白检测
  • 耗材及配件
  • 装置
    • 分析仪
    • 影像和监控设备

7. 心臟POC检测设备市场（依设备类型）

  • 桌上型 POC 设备
  • 手持式POC设备
  • 穿戴式POC设备

第 8 章：心臟 POC 测试设备市场（按应用）

  • 诊断和筛检
  • 监控

第 9 章：心臟 POC 测试设备市场（依最终用户）

  • 门诊手术中心
  • 诊断实验室
  • 主页设定
  • 医院

第 10 章：美洲心臟 POC 测试设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第 11 章亚太心臟 POC 测试设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲心臟POC检测设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023年市场占有率分析
  • 2023年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alfa Scientific Designs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cipla Limited
  • Compagnie Merieux Alliance SAS
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Getein Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • LifeSign LLC
  • Medtronic plc
  • Merck KGaA
  • Nano-Ditech Corp.
  • Nexus Dx, Inc.
  • Nova Biomedical Corporation
  • Polymer Technology Systems, Inc. by Sinocare
  • Precision Biosensor, Inc.
  • QuidelOrtho Corporation
  • Sekisui Chemical Co., Ltd.
  • Siemens Healthineers AG
  • Werfen, SA
Product Code: MRR-02026C4CB4BE

The Cardiac POC Testing Devices Market was valued at USD 1.36 billion in 2023 and is projected to grow to USD 1.52 billion in 2024, with a CAGR of 12.36%, reaching USD 3.08 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 1.36 billion
Estimated Year [2024] USD 1.52 billion
Forecast Year [2030] USD 3.08 billion
CAGR (%) 12.36%

The cardiac point-of-care (POC) testing market has evolved rapidly, driven by a confluence of technological advances, changing clinical needs, and demand for faster, reliable diagnostics. This dynamic field is redefining the way healthcare providers screen, diagnose, and manage cardiac conditions. Recent developments in biomarker detection and portable device engineering have resulted in highly efficient methods to rapidly assess cardiac health at the bedside or in remote settings.

Innovation and precision in diagnostic technology have become crucial for ensuring timely intervention in cardiac emergencies. As trends in patient care shift towards decentralization and patient-centric models, the relevance and applications of cardiac POC testing devices are expanding. The landscape for these devices is continuously set to experience transformative growth as the integration of advanced biomarker tests and sophisticated device engineering meets an urgent need for improved accuracy and operational flexibility.

This comprehensive overview explores the various angles of the cardiac POC testing market, shedding light on transformative market shifts, detailed segmentation insights, regional opportunities, major players, actionable strategic recommendations, and a persuasive call-to-action for decision-makers looking to capitalize on these developments.

Transformative Shifts Redefining Cardiac POC Testing

In recent years, the cardiac POC testing domain has undergone transformative shifts propelled by both technological breakthroughs and changes in clinical demand. A surge in innovation has led to the development of novel diagnostic methods that enhance early detection and ongoing monitoring of cardiac conditions. This transformation is marked by improvements in accuracy, speed, and the ability to deliver near-patient testing solutions, which ultimately contribute to better patient outcomes.

Key drivers of this shift include the integration of digital health tools and AI-assisted diagnostics, which are streamlining result interpretation and enabling more personalized treatment pathways. Advances in miniaturization and sensor technology have allowed instruments to become more portable and user-friendly, elevating their role across diverse healthcare settings. Furthermore, the focus on reducing the turnaround time for cardiac biomarker tests, alongside the integration of automated systems, is instrumental in mitigating diagnostic delays during critical periods.

These dynamic changes are shaping a market environment where rapid and accurate diagnosis is not just desirable but essential. As healthcare systems globally continue to strive for efficiency and improved patient care, the ongoing enhancements in device capabilities and diagnostic accuracy will undoubtedly set future standards and open up new avenues for market growth.

Key Insights from Market Segmentation Analysis

Understanding the intricate layers of market segmentation provides a robust framework for identifying opportunities and challenges within the cardiac POC testing market. An analysis based on product differentiates the market into segments such as Cardiac Biomarker Test, Consumables & Accessories, and Devices. The Cardiac Biomarker Test segment is itself subdivided further into specific tests including B-Type Natriuretic Peptide, Creatine Kinase-MB (CK-MB) Fraction, D-dimer Tests, Myoglobin Tests, and Troponin Tests. Meanwhile, the Devices segment is examined through the lens of Analyzers and Imaging & Monitoring Devices, highlighting the importance of both analytical performance and real-time monitoring capabilities.

Examining the market by device type exposes a division into Bench-top POC Devices, Handheld POC Devices, and Wearable POC Devices, each offering unique pros and cons based on clinical needs, portability, and ease-of-use. The application-based segmentation further divides the market into Diagnostics & Screening and Monitoring, reflecting the dual roles these devices serve in both early detection and ongoing management of cardiac conditions. Additionally, an analysis by end-user segments into Ambulatory Surgical Centers, Diagnostic Laboratories, Home Settings, and Hospitals, emphasizing the versatile utilization of these technologies across a spectrum of care environments.

This granular segmentation strategy illuminates key trends and requirements by blending technical specifications with practical applications. It helps stakeholders appreciate not only the technical diversity of the offerings but also the varied clinical settings that are adopting these diagnostic innovations. Such insights pave the way for targeted strategies that address the nuanced needs of each segment, ensuring that product development and market positioning are aligned with evolving clinical demands and patient-care paradigms.

Based on Product, market is studied across Cardiac Biomarker Test, Consumable & Accessories, and Devices. The Cardiac Biomarker Test is further studied across B-Type Natriuretic Peptide, Creatine Kinase-MB [CK-MB] Fraction, D-dimer Tests, Myoglobin Tests, and Troponin Tests. The Devices is further studied across Analyzers and Imaging & Monitoring Devices.

Based on Device Type, market is studied across Bench-top POC Devices, Handheld POC Devices, and Wearable POC Devices.

Based on Application, market is studied across Diagnostics & Screening and Monitoring.

Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, Home Settings, and Hospitals.

Regional Insights Driving Market Expansion

The global market for cardiac POC testing is shaped significantly by regional dynamics that influence both technology adoption and regulatory frameworks. In the Americas, robust healthcare infrastructure coupled with a strong focus on innovation in diagnostics fuels the pace of adoption while meeting high clinical standards. The region is characterized by a mature market environment with significant investments in research and development aimed at refining cardiac biomarker tests and associated devices.

Across Europe, the Middle East, and Africa, there is a growing acknowledgment of the importance of decentralized testing solutions, underpinned by strategic government initiatives and supportive healthcare policies. Sophisticated healthcare networks and a rising emphasis on patient monitoring have contributed to the expansion of POC testing solutions in this region. In particular, improving accessibility and reducing diagnostic time barriers have been pivotal in driving market penetration.

The Asia-Pacific region presents a dynamic growth landscape, characterized by rapid urbanization, rising healthcare awareness, and significant efforts to upgrade medical infrastructure. Emerging economies in this area have witnessed accelerated investments in healthcare technology, while simultaneous policy reforms and technological adoptions are enhancing access to advanced diagnostics. The region remains a hub of technological innovation, where investments in both centralized and decentralized diagnostic tools are propelling market growth and transforming how patient care is delivered.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights on Leading Companies Shaping the Market

The cardiac POC testing arena is bolstered by contributions from several influential companies whose innovations and market strategies are redefining diagnostic excellence. Industry frontrunners such as Abbott Laboratories, ACON Laboratories, Inc., and Alfa Scientific Designs, Inc. have developed state-of-the-art diagnostic tools that combine sensitivity, specificity, and user-friendly interfaces. Other key players like Bio-Rad Laboratories, Inc., Cipla Limited, and Compagnie Merieux Alliance SAS are equally pivotal in expanding global reach and driving technology adoption.

Notable multinational corporations such as Danaher Corporation, F. Hoffmann-La Roche Ltd, and Medtronic plc continue to invest heavily in R&D to refine existing offerings and develop next-generation devices. Innovative enterprises like Getein Biotech, Inc., LifeSign LLC, and Nano-Ditech Corp. are making significant strides by introducing cutting-edge technologies that cater to emerging markets. Additional contributions from Nexus Dx, Inc., Nova Biomedical Corporation, and Polymer Technology Systems, Inc. by Sinocare, Precision Biosensor, Inc., QuidelOrtho Corporation, Sekisui Chemical Co., Ltd., Siemens Healthineers AG, and Werfen, S.A. further underscore the highly competitive and collaborative nature of this market.

Each of these companies brings a unique blend of technological excellence and strategic market positioning. Their continued drive towards innovation, combined with an increasing emphasis on reliability and performance, is set to propel the overall growth of cardiac POC testing solutions across various clinical applications and geographies. These industry leaders not only shape market trends but also establish benchmarks that other players aspire to, continually encouraging advancements in the field.

The report delves into recent significant developments in the Cardiac POC Testing Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Cipla Limited, Compagnie Merieux Alliance SAS, Danaher Corporation, F. Hoffmann-La Roche Ltd, Getein Biotech, Inc., Laboratory Corporation of America Holdings, LifeSign LLC, Medtronic plc, Merck KGaA, Nano-Ditech Corp., Nexus Dx, Inc., Nova Biomedical Corporation, Polymer Technology Systems, Inc. by Sinocare, Precision Biosensor, Inc., QuidelOrtho Corporation, Sekisui Chemical Co., Ltd., Siemens Healthineers AG, and Werfen, S.A.. Strategic Recommendations for Market Leadership

For industry leaders aiming to capitalize on the expanding cardiac POC testing landscape, a strategic approach that integrates innovation, market intelligence, and customer-centric service is essential. Based on current industry developments, it is recommended that companies invest robustly in research and development to pioneer next-generation diagnostic tools that offer enhanced accuracy and speed. Forming strategic partnerships with research institutions and technology innovators can lead to breakthrough improvements in device performance, particularly in the realm of miniaturization and integrated digital platforms.

Market leaders should also focus on building resilient supply chains and optimizing manufacturing processes to ensure rapid scalability and cost-effectiveness. Tailoring product portfolios to meet the specific requirements of segmented market groups-ranging from comprehensive biomarker tests to versatile devices suitable for both clinical and home settings-will be vital. Furthermore, leveraging data analytics to understand consumer behavior and regional disease patterns can provide a competitive edge in customizing solutions that address local healthcare challenges.

Emphasis should be placed on expanding market presence in regions with high growth potential while remaining adaptive to regulatory changes and technological advancements. Building strong customer support networks and training programs can ensure that new technologies are effectively implemented and sustained. By adopting a holistic and agile approach, companies can safeguard their market share and drive ongoing success in a competitive and evolving field.

Conclusion: Paving the Way for a Healthier Future

In conclusion, the landscape of cardiac POC testing devices is marked by rapid innovation, diverse clinical applications, and substantial growth opportunities. Technological advancements are continuously reshaping the industry, enhancing the accuracy and speed of diagnostic tests while providing critical support in both emergent and routine care settings. Detailed segmentation insights reveal the multifaceted nature of this market, from specialized biomarker tests to advanced device categories that cater to various clinical and home environments.

The regional dynamics underscore the importance of targeted strategies, given the differing regulatory frameworks, technological maturity, and healthcare infrastructures across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Furthermore, the active role of key market players is instrumental in setting industry standards and driving adoption through continuous innovation and strategic market expansion.

Ultimately, these insights not only provide a roadmap for current market trends but also highlight the pivotal role that strategic planning and technological integration play in shaping the future of cardiac care. As stakeholders work together to advance the state of diagnostic health, the collective efforts contribute significantly to improving patient outcomes and fostering a healthier, more proactive approach to cardiac management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cardiac disorders and rising geriatric population globally
      • 5.1.1.2. Inclination toward the early detection and diagnosis of patients
      • 5.1.1.3. Favorable government support for cardiac health
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk of product recall in Cardiac POC testing devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Implementation of unique & new troponin-based test
      • 5.1.3.2. Positive investment and startup ecosystem
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations and concerns associated with the accuracy of cardiac POC testing devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Favorable regulatory approvals for various cardiac POC testing devices
    • 5.2.2. Device Type: Exploration of wearable POC devices to provide convenient homecare for managing heart conditions
    • 5.2.3. Application: Critical role played by effective diagnostics & screening procedures in the management of cardiac diseases
    • 5.2.4. End-User: Extensive and comprehensive care provided by hospitals for improving cardiac health
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac POC Testing Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Biomarker Test
    • 6.2.1. B-Type Natriuretic Peptide
    • 6.2.2. Creatine Kinase-MB [CK-MB] Fraction
    • 6.2.3. D-dimer Tests
    • 6.2.4. Myoglobin Tests
    • 6.2.5. Troponin Tests
  • 6.3. Consumable & Accessories
  • 6.4. Devices
    • 6.4.1. Analyzers
    • 6.4.2. Imaging & Monitoring Devices

7. Cardiac POC Testing Devices Market, by Device Type

  • 7.1. Introduction
  • 7.2. Bench-top POC Devices
  • 7.3. Handheld POC Devices
  • 7.4. Wearable POC Devices

8. Cardiac POC Testing Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics & Screening
  • 8.3. Monitoring

9. Cardiac POC Testing Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Diagnostic Laboratories
  • 9.4. Home Settings
  • 9.5. Hospitals

10. Americas Cardiac POC Testing Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac POC Testing Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac POC Testing Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Siemens Healthineers launches NT-proBNPII assay on Atellica platform to enhance heart failure diagnosis and speed patient care
    • 13.3.2. F. Hoffmann-La Roche AG launches NT-proBNP point-of-care test on cobas h 232 to enhance early detection and management of CVD and heart failure in diabetes patients
    • 13.3.3. Analytics for Life and CorVista Health receive FDA clearance for non-invasive CorVista System with Pulmonary Hypertension
    • 13.3.4. Eko Health, Inc. and Mayo Clinic secure FDA clearance for AI-driven low ejection fraction detection
    • 13.3.5. SpinChip Diagnostics receives NOK 115 million investment from bioMerieux to commercialize next-generation cardiac POC testing devices
    • 13.3.6. Roche to acquire LumiraDx's microfluidic point-of-care technology to advance cardiovascular diagnostics
    • 13.3.7. Primary Healthtech's Mobilab device offers early detection of heart and chronic diseases with IoT integration
    • 13.3.8. EDX Medical Group Plc. acquires Hutano Diagnostics Ltd. to develop advanced smartphone-integrated POC tests
    • 13.3.9. EDX Medical Group acquires Hutano Diagnostics to revolutionize rapid healthcare tests with advanced diagnostic technology enhancing speed, accuracy, and cost-effectiveness
    • 13.3.10. Cipla launches cippoint, POC testing device to expand diagnostics portfolio with CE IVD approval, enhancing rapid clinical decision-making and market penetration
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. F. Hoffmann-La Roche Ltd.
    • 13.4.2. Siemens Healthineers AG
    • 13.4.3. Abbott Laboratories
    • 13.4.4. Danaher Corporation
    • 13.4.5. Werfen, S.A.

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACON Laboratories, Inc.
  • 3. Alfa Scientific Designs, Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Cipla Limited
  • 6. Compagnie Merieux Alliance SAS
  • 7. Danaher Corporation
  • 8. F. Hoffmann-La Roche Ltd
  • 9. Getein Biotech, Inc.
  • 10. Laboratory Corporation of America Holdings
  • 11. LifeSign LLC
  • 12. Medtronic plc
  • 13. Merck KGaA
  • 14. Nano-Ditech Corp.
  • 15. Nexus Dx, Inc.
  • 16. Nova Biomedical Corporation
  • 17. Polymer Technology Systems, Inc. by Sinocare
  • 18. Precision Biosensor, Inc.
  • 19. QuidelOrtho Corporation
  • 20. Sekisui Chemical Co., Ltd.
  • 21. Siemens Healthineers AG
  • 22. Werfen, S.A.

LIST OF FIGURES

  • FIGURE 1. CARDIAC POC TESTING DEVICES MARKET MULTI-CURRENCY
  • FIGURE 2. CARDIAC POC TESTING DEVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. CARDIAC POC TESTING DEVICES MARKET RESEARCH PROCESS
  • FIGURE 4. CARDIAC POC TESTING DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 24. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC POC TESTING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. CARDIAC POC TESTING DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CREATINE KINASE-MB [CK-MB] FRACTION, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY D-DIMER TESTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MYOGLOBIN TESTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN TESTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CONSUMABLE & ACCESSORIES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMAGING & MONITORING DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY BENCH-TOP POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HANDHELD POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY WEARABLE POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 24. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTICS & SCREENING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 26. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MONITORING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 28. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 29. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 30. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 31. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 32. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 33. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 34. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 35. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 36. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 37. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 38. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 39. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 40. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 41. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 42. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 43. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 44. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 45. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 46. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 47. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 48. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 49. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 50. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 51. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 52. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 53. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 54. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 55. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 56. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 57. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 58. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 59. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 60. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 61. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 62. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 63. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 64. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 65. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 66. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 67. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 68. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 69. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 70. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 71. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 72. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 73. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 74. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 75. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 76. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 77. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 78. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 79. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 80. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 81. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 82. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 83. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 84. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 85. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 86. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 87. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 88. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 89. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 90. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 91. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 92. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 93. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 94. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 95. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 96. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 97. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 98. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 99. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 100. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 101. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 102. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 103. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 104. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 105. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 106. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 107. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 108. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 109. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 110. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 111. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 112. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 113. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 114. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 115. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 116. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 117. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 118. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 119. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 120. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 121. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 122. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 123. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 124. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 125. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 126. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 127. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 128. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 129. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 130. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 131. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 132. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 133. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 134. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 135. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 136. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 137. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 138. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 139. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 140. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 141. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 142. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 143. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 144. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 145. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 146. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 147. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 148. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 156. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 157. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 158. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 159. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 160. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 161. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 162. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 163. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 164. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 165. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 166. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 167. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 168. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 169. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 170. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 171. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 172. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 173. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 174. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 175. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 176. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 177. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 178. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 179. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 180. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 181. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 182. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 183. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 184. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 185. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 186. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 187. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 188. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 189. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 190. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 191. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 192. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 193. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 194. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 195. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 196. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 197. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 198. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 199. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 200. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 201. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 202. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 203. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 204. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 205. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 206. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 207. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 208. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 209. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 210. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 211. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 212. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 213. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 214. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 215. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 216. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 217. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 218. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 219. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 220. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 221. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 222. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 223. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 224. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 225. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 226. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 227. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 228. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 229. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 230. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 231. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 232. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 233. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 234. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 235. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 236. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 237. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 238. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 239. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 240. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 241. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 242. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 243. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 244. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 245. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 246. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 247. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 248. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 249. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 250. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 251. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 252. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 253. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 254. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 255. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 256. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 257. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 258. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 259. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 260. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 261. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 262. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 263. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 264. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 265. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 266. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 267. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 268. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 269. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 270. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 271. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 272. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 273. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 274. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 275. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 276. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 277. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 278. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 279. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 280. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 281. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 282. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023